Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ACAM2000
Manufacturing
Emergent BioSolutions' mpox preparedness orders reach $400M
The company has delivered on orders worth nearly $210 million for its mpox and smallpox vaccine, as well as its vaccine complications treatment.
Zoey Becker
Sep 25, 2024 1:06pm
Emergent's smallpox vaccine wins FDA approval for mpox
Aug 30, 2024 11:23am
Acquisitive Emergent BioSolutions buys PaxVax for $270M
Aug 13, 2018 12:25pm
Dynavax, Emergent and more—News of Note
Aug 8, 2018 7:59am
